Inocras Secures $31.0M Series B Funding

Proxy Foods AI

Proxy Foods | AI-Powered Formulation & Product Development Proxy Foods is the world’s first and most advanced AI product development and recipe formulation platform-trusted by leading R&D teams to create, reformulate, and optimize food & beverage products consumers love, at scale and in record time. We help teams launch and reformulate faster-delivering better, healthier products without sacrificing taste or margins. From concept to shelf, Proxy accelerates innovation with data-driven insights, AI agents, and human-in-the-loop validation: move from concept to prototype in minutes, get pilot-ready in days, iterate rapidly with feedback-driven optimization (including auto-generated DoEs), and scale confidently into production. For reformulation, renovation, and optimization, Proxy helps improve flavor, texture, nutrition, and shelf life, reduce sodium/sugar/chemicals for cleaner labels, incorporate market + sensory insights, and optimize cost, yield, and process decisions-while keeping recipe identity and brand consistency intact. Use Proxy out-of-the-box, or securely integrate with internal systems to adapt the AI to your products, consumers, and process-powered by an agentic workflow built for disciplined formulation, rapid iteration, and scientific rigor. Learn more: https://proxyfoods.ai

Claryx

Claryx is building the hospital immune system. We read the genomes of confirmed patient infections, link related cases as outbreaks, and trace each back to its likely source. When that source is in the building (a sink, an ice machine, a scope moving between rooms), we find it against a digital twin of the hospital's microbiome, sequenced from its air, its water and its surfaces, all on proprietary chemistry cheap enough to run continuously. Founded by brothers Kurt and Dirk Hackenberger, Claryx is based in New York and live across multiple health systems. Find us at www.claryx.com. Reach us at contact@claryx.com.